Response to Pyridostigmine in Congenital Myasthenia with LRP4 Mutation
- PMID: 39739258
- DOI: 10.1007/s12098-024-05381-x
Response to Pyridostigmine in Congenital Myasthenia with LRP4 Mutation
Conflict of interest statement
Declarations. Conflict of Interest: None.
References
-
- Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019; https://doi.org/10.1186/s13023-019-1025-5.
-
- Ramdas S, Beeson D. Congenital myasthenic syndromes: where do we go from here? Neuromuscul Disord. 2021;31:43–54.
-
- Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015;14:420−34. Erratum in: Lancet Neurol. 2015;14:461.
-
- Cho A, Yeon KS, Lee JS, et al. Wide heterogenecity of congenital myasthenic syndromes: analysis of clinical experience in a tertiary center. J Genet Med. 2020;17:73–8.
Publication types
LinkOut - more resources
Miscellaneous